After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ABBV belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Abbvie Inc is $378.30B. A total of 6.78 million shares were traded on the day, compared to an average of 6.06M shares.
In the most recent transaction, GONZALEZ RICHARD A sold 92,460 shares of ABBV for 205.11 per share on Feb 28 ’25. After the transaction, the Director now owns 395,097 company shares. In a previous transaction on Mar 03 ’25, GONZALEZ RICHARD A sold 6,168 shares at 210.53 per share. ABBV shares that Director owns now total 388,929.
Among the insiders who sold shares, Siatis Perry C disposed of 18,008 shares on Mar 03 ’25 at a per-share price of $210.00. This resulted in the EVP, GC AND SECRETARY holding 4,619 shares of ABBV after the transaction. In another insider transaction, Siatis Perry C sold 9,892 shares at $206.30 per share on Feb 28 ’25. Company shares held by the EVP, GC AND SECRETARY now total 4,619.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Abbvie Inc pays an annual dividend of $6.29, resulting in a dividend yield of 2.94%, and it has a price to earnings (P/E) ratio of 89.60. ABBV’s most recent ex-dividend date was 3.4% when it declared a $1.64 quarterly dividend that was paid in cash on 4/15/2025. Previously, the company paid the dividend on 1/15/2025 with an ex-dividend date of 3.46%. The ABBV stock dividend was $1.64 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ABBV has a high of $215.66 and a low of $153.58.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ABBV’s latest balance sheet shows that the firm has $9.83B in Cash & Short Term Investments as of fiscal 2021. There were $76.68B in debt and $35.19B in liabilities at the time. Its Book Value Per Share was $1.88, while its Total Shareholder’s Equity was $15.44B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABBV is Buy with a score of 4.25.
